AN MoU was signed by abu Dhabi's Department of Health, ADIO, Etihad Airways and AD Ports Group at the recent BIO International Convention in California to strengthen emirate's position as a global pharmaceutical and life science hub.
The partnership aims to strengthen Abu Dhabi's role as a distribution hub, leveraging its strategic location, advanced healthcare infrastructure and capabilities as well as lucrative investment opportunities, reports the American Journal of Transportation.
As part of the agreement, the entities will work together to ensure timely access to innovative healthcare products for patients across the region.In the presence of His Excellency Mansoor Ibrahim Al Mansouri, chairman of the Department of Health - Abu Dhabi (DoH) and Khalifa Al Mahmoud, International Operations at Abu Dhabi Investment Office (ADIO), the MoU was signed by Dr Asma Ibrahim Al Mannaei executive director of the Research and Innovation Centre at DoH, Stanislas Brun, vice president of Etihad Cargo, and Mansoor Al Marar, vice president, Industrial Business Development at KEZAD Group, a subsidiary of AD Ports Group.
In line with the Abu Dhabi Economic Vision 2030, the MoU is a pivotal step in Abu Dhabi's ongoing efforts to become a leading healthcare destination in the global healthcare landscape.
The partnership aims to create attractive value propositions for pharmaceutical, biotechnology, and medical technology companies to establish their operations in Abu Dhabi.
Dr Asma Ibrahim Al Mannaei, head of the research and innovation at DoH, was present at the signing and emphasised the importance of this initiative, stating, 'Leveraging Abu Dhabi's strategic location at the gateway to the MENA region, we are pleased to partner with world-class leaders in investment and logistics.
SeaNews Turkey
The partnership aims to strengthen Abu Dhabi's role as a distribution hub, leveraging its strategic location, advanced healthcare infrastructure and capabilities as well as lucrative investment opportunities, reports the American Journal of Transportation.
As part of the agreement, the entities will work together to ensure timely access to innovative healthcare products for patients across the region.In the presence of His Excellency Mansoor Ibrahim Al Mansouri, chairman of the Department of Health - Abu Dhabi (DoH) and Khalifa Al Mahmoud, International Operations at Abu Dhabi Investment Office (ADIO), the MoU was signed by Dr Asma Ibrahim Al Mannaei executive director of the Research and Innovation Centre at DoH, Stanislas Brun, vice president of Etihad Cargo, and Mansoor Al Marar, vice president, Industrial Business Development at KEZAD Group, a subsidiary of AD Ports Group.
In line with the Abu Dhabi Economic Vision 2030, the MoU is a pivotal step in Abu Dhabi's ongoing efforts to become a leading healthcare destination in the global healthcare landscape.
The partnership aims to create attractive value propositions for pharmaceutical, biotechnology, and medical technology companies to establish their operations in Abu Dhabi.
Dr Asma Ibrahim Al Mannaei, head of the research and innovation at DoH, was present at the signing and emphasised the importance of this initiative, stating, 'Leveraging Abu Dhabi's strategic location at the gateway to the MENA region, we are pleased to partner with world-class leaders in investment and logistics.
SeaNews Turkey
